Abstract:
Rhinovirus infections are linked to the development and exacerbation of allergic diseases including allergic asthma. IgE, another contributor to atopic disease pathogenesis, has been shown to regulate dendritic cell antiviral functions and influence T cell priming by monocytes.
We previously demonstrated that IgE-mediated stimulation of monocytes alters multiple cellular functions including cytokine secretion, phagocytosis, and influenza-induced Th1 priming. In this study, we investigate the effects of IgE-mediated allergic stimulation on monocyte-driven, RVinduced T cell priming utilizing primary human monocyte-T cell co-cultures. We demonstrate that IgE crosslinking of RV-exposed monocytes enhances monocyte-driven Th2 priming while inhibiting Th1 differentiation. This increase in RV-induced Th2 differentiation was regulated by IgE-mediated induction of IL-10 and inhibition of type I interferon. These findings suggest an additional mechanism by which two clinically significant risk factors for allergic disease exacerbations -IgE-mediated stimulation and rhinovirus infection, may synergistically promote Th2 differentiation and allergic inflammation.
Introduction:
The link between viruses and allergic diseases has long been appreciated, and is best represented by the coinciding increase in allergic asthma exacerbations with peaks in fall respiratory virus epidemics (1) . Rhinoviruses (RV) are closely associated with allergic disease, representing the most frequently detected viruses in children with asthma exacerbations (1, 2) .
Early RV infection in allergic children also increases the risk of asthma development by 8-fold (3) . The degree of atopy is similarly linked to disease severity; for example, serum allergenspecific IgE levels in allergic asthmatics directly correlate with virus-induced exacerbation severity (4). Clinically, decreasing serum IgE with omalizumab therapy reduces atopic disease exacerbations (5-7). In a recent study, children with allergic asthma treated with omalizumab had decreased RV-induced upper respiratory symptoms, shortened duration of virus shedding, and decreased peak virus titers (8) , suggesting that IgE-mediated processes modulate RV infection in vivo.
Monocytes, antigen presenting cells (APCs) recruited to tissues during virus-induced allergic exacerbations (9) , are modulated by the allergic environment (10-13). Several studies indicate roles for monocytes and monocyte-derived cells in RV-induced allergic disease pathogenesis. In asthmatic subjects, experimental RV-infection induced recruitment of monocytes and macrophages to the airways, which correlated with virus load, symptom scores and airway reactivity (9) . Our group has shown that IgE crosslinking induces monocyte secretion of regulatory and pro-inflammatory cytokines, including IL-10, IL-6, and TNFa (11). IL-10 has been specifically linked to allergic disease pathogenesis and virus-induced wheezing (14-16), although its role in IgE-mediated monocyte antiviral responses remains unexplored. We recently demonstrated that critical monocyte antiviral functions, including influenza-induced upregulation of antigen-presenting molecules and CD4 Th1 T cell priming are inhibited by IgE crosslinking (10) . IgE-mediated regulation of monocyte functions during RV infection may thus play a role in promoting allergic inflammation.
Th2-mediated responses, a hallmark of allergic disease, are implicated in RV-induced inflammation. Enhanced Th2 inflammatory responses correlate with increased disease severity in allergic asthmatics experimentally infected with RV (17) . While multiple cell types and mediators are likely involved, many studies support a role for both APCs and IgE in promoting Th2 responses. In cat allergic subjects, omalizumab treatment decreased ex vivo allergen-induced pDC-driven Th2 stimulation (18) ; similarly, monocyte-derived DCs from allergen-exposed atopic subjects induced CD4 T cell Th2 cytokine responses (19) . These studies suggest that IgEmediated APC stimulation may regulate Th2 priming during RV-induced allergic inflammation, although the mechanisms underlying this phenomenon remain undefined.
Type I interferons (IFN) are critical mediators of virus infection and also negatively regulate human Th2 development and effector functions in vitro (20, 21) . IgE-mediated inhibition of APC antiviral IFN responses is one proposed mechanism involved in RV-induced allergic exacerbations (5, 22) . IgE crosslinking inhibits influenza-and RV-induced IFN secretion from plasmacytoid dendritic cells (pDCs) and PBMCs (22) (23) (24) , and omalizumab treatment in children with allergic asthma has recently been shown to restore these ex vivo antiviral IFN responses (22) . Furthermore, the group with the greatest post-omalizumab increases in IFN had fewer asthma exacerbations (5), suggesting that virus-induced type I IFN plays an important role in regulating allergic inflammation in vivo.
While IgE-mediated effects likely contribute to virus-induced allergic disease, how IgE regulates antiviral responses to RV and promotes Th2-mediated allergic inflammation is unknown. Given the critical role of monocytes and monocyte-derived cells in antigen presentation and T cell differentiation, we investigated the impact of IgE-mediated stimulation on RV-induced monocyte-driven T cell differentiation. We show that IgE-driven effects on monocyte functions, including IL-10 production and inhibition of virus-induced IFN, enhance RV-induced Th2 development. These data provide evidence that IgE-mediated alteration of monocyte antiviral functions during RV infection may promote Th2-mediated inflammation to enhance allergic inflammation.
Results:

IgE-mediated allergic stimulation enhances RV-induced monocyte-driven CD4 Th2 cell development
We previously established a model of monocyte-driven T cell development to evaluate the effects of IgE-mediated allergic stimulation on monocyte-driven T cell priming (10) . Using this system, we determined the impact of IgE-mediated stimulation on RV-induced naïve CD4 T cell priming by primary human monocytes ( Figure 1 and Supplemental Figure 1 ). RV-exposure induced a small but significant increase in monocyte-driven Th2 differentiation (Fig. 1A) .
Notably, IgE crosslinking of monocytes significantly enhanced RV-driven Th2 priming ( Fig.   1A ) which positively correlated with baseline surface expression of the high affinity IgE receptor on monocytes (FceRIa, Fig 1B) . Similar to previous findings with influenza (10) , the strong Th1 response induced by RV-exposed monocytes was inhibited by IgE crosslinking (Fig. 1C) , significantly altering the Th1/Th2 ratio (Fig. 1D ). These data suggest that IgE-mediated allergic stimulation of human monocytes enhances RV-induced Th2 differentiation, shifts the Th1/Th2 balance towards allergic inflammation, and is related to monocyte FceRIa expression.
IgE-induced IL-10 regulates RV-induced Th2 development
To investigate potential mechanisms underlying IgE-induced RV-driven Th2 development, we evaluated the role of monocyte-secreted cytokines. IgE-mediated stimulation of monocytes results in the production of IL-10 (11, 13), a cytokine known to regulate proinflammatory processes, including T cell development (25) (26) (27) . Monocytes secreted IL-10 in response to IgE crosslinking, which was not altered by RV-exposure ( Figure 2A ). Blocking IL-10 reversed IgE-induced enhancement of RV-driven Th2 differentiation (Fig. 2B ), without affecting Th1 differentiation (Fig. 2C ). As expected, exogenous addition of IL-10 was not sufficient alone to enhance RV-induced monocyte-driven Th2 development (Fig. 2D ), consistent with previous findings that IL-10 requires additional factors to influence Th2 development in naïve CD4 T cells (26, 27) . These results indicate that additional IgE-mediated effects on monocytes combined with increased IL-10 secretion are required to enhance RV-induced Th2 development.
Type I interferon (IFN) negatively regulates RV-induced Th2 development
We next investigated the effects of IgE crosslinking on RV-induced IFN, a negative regulator of Th2 development. IgE crosslinking significantly impaired RV-induced monocyte secretion of IFNa 24h post virus exposure ( Figure 3A) . Exogenous IL-10 similarly inhibited RV-induced IFNa secretion (Fig. 3B) . Blocking IL-10 in monocyte-T cell co-cultures partially reversed IgE-mediated inhibition of IFNa (Fig. 3C) 
Methods:
Human Subjects
Samples were acquired from 2 sources: leukocyte-enriched blood samples from unknown donors through a local blood bank and blood samples from healthy volunteers. Unknown donors were deemed healthy enough for routine blood donation by the local blood bank. Studies were approved by the UT Southwestern institutional review board (Study # STU 122010-139). For known volunteers, written informed consent and assent were obtained.
Reagents and Media
Phosphate Buffered Saline (PBS) with fetal bovine serum (FBS) and EDTA (complete PBS, cPBS) and complete Roswell Park Memorial Institute Medium 1640 (cRPMI) were prepared as previously described (11) . Rabbit anti-human IgE (αIgE) was purchased from Bethyl Laboratories (Montgomery, TX) and rabbit whole IgG control antibody (IgG) from Jackson ImmunoResearch (Westgrove, PA). Unless specified, recombinant human (rh) cytokines, antihuman cytokine and receptor antibodies were purchased from R&D Systems (Minneapolis, MN).
Purification of Immune Cells from Blood
Monocytes and naïve CD4 + T cells were purified as previously described (10, 11) . Purity was assessed by flow cytometry; monocytes were identified as CD14+ and naïve CD4 + T cells as CD3+CD4+CD45RA+. Samples with <85% purity were excluded.
Monocyte Culture Conditions
Monocytes were cultured in cRPMI with recombinant human (rh) M-CSF (1 ng/ml) at a concentration of 1 x 10 6 cells/ml. αIgE (10 µg/ml), rabbit IgG isotype control (10 µg/ml), or IL-10 (10 ng/ml), anti-IL-10 and anti-IL-10 receptor (IL10Ra) (5µg/mL each), or mouse IgG isotype controls were added to monocyte cultures at the start of culture. Purified Rhinovirus A serotype 16 (RV) (kindly provided by Jim Gern and Yury Bochkov, U Wisconsin) was added at a multiplicity of infection (MOI) 10. Cultures were incubated at 37°C for indicated times. Cells and supernatants were harvested for analysis or for T cell co-culture experiments.
Monocyte-T Cell Co-Culture
Monocytes were cultured as above in the presence or absence of αIgE, control IgG, or RV at 37°C for 18-24 hours and then mixed 1:1 with allogeneic naïve CD4 + T cells. Cells were cultured in media containing 50 Units/mL recombinant human IL-2. For select experiments, mouse anti-human antibodies against IL-10, IL-10Rα, or IFNAR and IgG1 or IgG2b isotype controls were added at 5-10µg/mL each for a total mouse IgG concentration of 10 µg/ml prior to co-culture with T cells. As indicated, recombinant human (rh) IFNa (1000-10,000 IU/mL) was added at the initiation of co-culture. After 3 days of co-culture, T cells were cultured for an additional 3-4 days, rested and restimulated for flow cytometry analysis as previously described (10) .
Flow Cytometry Analysis of Surface Antigens
The following fluorochrome-conjugated anti-human antibodies or molecules were used: CD3-peridinin chlorophyll protein complex (PerCP), CD4-allophycocyanin (APC), CD14-V450, CD45RA-phycoethrin (PE), FcεRIa-fluorescein (FITC), HLA-DR-APC-Cy7, and HLA-DR-FITC (BD Pharmingen, San Diego, CA). Staining and flow cytometry were performed as previously described (11) . Samples were acquired on a BD LSR II flow cytometer (BD Biosciences) and analyzed with the FlowJo 8 software (FLOWJO, LLC, Ashland, OR).
Flow Cytometry Analysis of Intracellular Cytokines
The following antibodies were used: IFNγ-PE-Cy7 and IL-4-PE (BD Biosciences, San Jose, CA). Cells were fixed in 2% paraformaldehyde and permeablized with 0.1% saponin in PBS to detect intracellular antigens. Samples were acquired and analyzed as above described. Gating of cytokine-expressing cells was guided by staining negative control (unstimulated cells) and positive control T cells differentiated under Th1-or Th2-inducing conditions (21) . Percentages of total cytokine-positive populations were then determined. Th2 cells were identified as IL-4 single positive; Th1 cells were identified as the total IFNg population (Supplemental Figure 1) .
Cytokine Secretion Analysis
Supernatants were stored at -80°C until use. The following ELISA kits were used according to manufacturer recommendations: ELISA Max human ELISA for IL-10 (Biolegend, San Diego, CA), anti-pan human IFN alpha (Interferon Source, Cincinnati, OH). Absorbance was measured on a Biorad iMark microplate reader (Biorad, Hercules, CA) per manufacturer's instructions.
Data Analysis and Statistics
Data are presented as means ± standard error of the mean (SEM) or standard deviation (SD All statistical analyses were performed using GraphPad Prism version 8. 
